Ehrlich ascites carcinoma

African Journal of Biotechnology

Volumn 10, Issue 13, 2011, Pages 2375-2378

  Ozaslan, Mehmet ^a   Karagoz, Isik Didem ^a   Kilic, Ibrahim Halil ^a   Guldur, Muhammed Emin ^b  

^a GAZIANTEP UNIVERSITY   (Turkey)

^b HARRAN UNIVERSITY   (Turkey)

Author keywords

Carcinoma; Transplantability

Indexed keywords

DACTINOMYCIN; DOXORUBICIN; IRINOTECAN; TAXANE DERIVATIVE; TOPOTECAN; VINBLASTINE; VINCRISTINE;

ASCITES FLUID; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER TRANSPLANTATION; CELL DIVISION; CELL PROLIFERATION; EHRLICH ASCITES TUMOR; HERBAL MEDICINE; INOCULATION; LIVER REGENERATION; NATURAL KILLER CELL; NONHUMAN; PHASE TRANSITION; REVIEW; T LYMPHOCYTE ACTIVATION; TUMOR CELL; TUMOR GROWTH;

EID: 79953653554     PISSN: 16845315     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (50)

1. Aktaş E (1996). Ehrlich Asit Si{dotless}vi{dotless}si{dotless}ni{dotless}n L-Hücrelerinin Çoǧalma Hi{dotless}zi{dotless}na Etkisi. Yüksek Lisans Tezi. İstanbul Üniversitesi Fen Bilimleri Enstitüsü. İstanbul.
2. Altun S (1996). Normal, Tümöral ve Rejeneratif Büyümeler Arasi{dotless}ndaki Kinetik İlişkiler. Tradit. J. Biol. Tübitak. 20(3): 153-173.
3. Balint Z, Holczinger L (1984). Changes in Lipoprotein Lipase Activity (LPLA) in Tumor Cells and Tissues in Mice Bearing Ehrlich Ascites Tumor. Bull. Cancer, 71(5).
4. Bhakuni DS, Dhar ML, Dhar MM, Dhawan BN, Hehrotra BN (1969). Screening of Indian Plants for Biological Activity. Part II. Indian J. Exp. Biol. 7: 250-262.
5. Bulan Ö (1990). Ehrlich Ascites Tümör Hücrelerinde Yaşlanma ile Hücre Kinetiǧi Arasi{dotless}ndaki İlişkiler. Yüksek Lisans Tezi. İstanbul Üniversitesi Fen Bilimleri Enstitüsü. İstanbul.
6. Burns ER (1968). Initiation of DNA Synthesis in Ehrlich Ascites Tumor Cells in Their Plateau Phase of Growth. Cancer Res. 28: 1191-1196.
7. Burns ER, Yeh H, Yeh Y (1983). Initiations of DNA Synthesis in the Parotid Salivary Gland of Adult Mice by a Factor Isolated From Acellular Fluid of Ehrlich Ascites Carcinoma. Biosci. Rep. 3(2): 113-125.
8. Cragg GM, Newmann D (1999). Discovery and Development of Antineoplasic Agents from Natural Sources. Cancer Investigation, 17: 153-163.
9. Donenko FV, Kabieva AO, Moroz LV (1992). In vivo Model of Ehrlich Carcinoma and Teratoma T-36 Growth by Ascitic Fluid and Dialysate of Ehrlich Tumor Cells. Biull. Exp. Biol. Med. 114(8): 193-195.
10. Duke JA (1985). CRC Handbook of Medicinal Herbs. CRC Pres International Inc. pp. 272-276.
11. Ehrlich P, Apolant H (1905). Beobachtungen Über Maligne Mausentumoren. Berlin. Klin. Wschr. 28: 871-874.
12. Ekinci G (2000). Kati{dotless} Ehrlich Ascites Tümörünün Büyüme Kinetiǧi. İstanbul Üniversitesi Fen Bilimleri Enstitüsü. İstanbul.
13. Estrela MJ, Hernandez R, Terradez P, Asensi M, Puertes R, Vina J (1992). Regulation of Glutathione Metabolism in Ehrlich Ascites Tumour Cells. Biochem. J. 286: 257-262.
14. Gabrilovac J, Benkovic B, Burek B, Cepelak I, Boranic M (1982). Immunoregulatory Activity of Cell-Free Peritoneal Washings of Mice with Ehrlich Ascitic Carcinoma. Res. Exp. Med. 180: 147-154.
15. Grune T, Siems W, Uhlig R, Jakstadt M (1992). Adenine Metabolism of Ehrlich Mouse Ascites Cells in Proliferating and Resting Phases of Tumor Growth. Biochemical Int. 26(2): 199-209.
16. Gümüşhan H (2002). İ.P., İ.V., S.C., Yollarla Uygulanan Adriamycin'in Ehrlich Asit Tümörü (EAT) Taşi{dotless}yan Farelere Etkileri Üzerine Bir Çali{dotless}şma. Harran Üniversitesi Fen Bilimleri Enstitüsü. Yüksek Lisans Tezi. Şanli{dotless}urfa.
17. Haris WJ, Meyskens F, Patt MH (1970). Biochemical Studies of Cytokinetic Changes During Tumor Growth. Cancer Res. 30: 1937-1946.
18. Kaleoǧlu Ö, İşli N (1977). Ehrlich-Lettre Asit Tümörü. Ti{dotless}p Fakültesi Mecmuasi{dotless}. 40: 978-984.
19. Kayaalp O (1996). Ti{dotless}bbi Farmakoloji. Hacettepe Taş Kitapçi{dotless}li{dotless}k. ISBN: 975-7731-23-4. 79-322. Ankara.
20. Klein G (1951). Comparative Studies of Mouse Tumors with Respect to Their Capacity for Growth as ''Ascites Tumors'' and Their Average Nucleic Acid Content Per Cell. Experimental Cell Research. 2: 518-573.
21. Latha PG, Evans DA, Panikkar KR, Jayavardhanan KK (2000). Immunomodulatory and Antitumor Properties of Psoralea corylfolia Seeds. Fitoterapia, 71: 223-231.
22. Lazebnik YA, Medvedeva DN, Zenin VV (1991). Reversible G2 Block in the Cell Cycle of Ehrlich Ascites Carcinoma Cells. Exp. Cell Res. 195: 247-254.
23. Lennartz KJ, Maurer W, Eder M (1968). Autoradiographic Analysis of the Cell Cycle of Ascites Tumors (Mouse) of Various Chromosome Stemlines and Different Origin. Z. Krebsforsch. 71: 267-282.
24. Lettre R, Paweletz N, Werner D, Granzow C (1972). Sublines of the Ehrlich-Lettre Mouse Ascites Tumor, A New Tool for Experimental Cell Research. Naturwissenschaften, 59: 59-63.
25. Lobo C, Ruiz-Bellido MA, Aledo JC, Marquez J, De Castro IN, Alonso FJ (2000). Inhibition of Glutaminase Expression by Antisense mRNA Decreases Growth and Tumourigenicity of Tumour Cells. Biochem. J. 348: 257-261.
26. Loewenthal H, Jahn G (1932). Übertragung-Suersuche Mit Carcinomatöser Mause-Asciteslussigleit Und İhr Verhalten Gegen Physikalische Und Chemische Einwirkungen. Z. Krebsforsch. 37: 439-447.
27. Marquez J, Sanchez-Jimenez F, Medina MA, Quesada AR, De Castro IN (1989). Nitrogen-Metabolism in Tumor-Bearing Mice. Arch. Biochem. Biophys. 268: 667-675.
28. Mascarenhas M (1994). Structure-Activity Characterization, a Quick Method to Screen Mushrooms for the Presence of Antitumor Glucans. Mushroom Res. 3: 77-80.
29. Mycek MJ, Harvey RA, Champe PC (1998). Lippincott's Illustrated Reviews Serisinden. Farmakoloji.
30. Okay HG (1998). Deneysel EAT Oluşturulan Fare Karaciǧer Plazmasi{dotless}nda Nitrik Oksit Metabolizmasi{dotless}ni{dotless}n İncelenmesi. Yüksek Lisans Tezi. İstanbul Üniversitesi Saǧli{dotless}k Bilimleri Enstitüsü. Biyokimya ABD. İstanbul.
31. Öner D (1985). Ehrlich Ascites Tümör Hücrelerinde Vincristin'e Karşi{dotless} Duyarli{dotless}li{dotless}ǧi{dotless}n Tümör Yaşi{dotless} ile İlişkisi. İstanbul Üniversitesi Fen Bilimleri Enstitüsü Radyoloji ve Saǧli{dotless}k Fizyolojik Araşti{dotless}rma ve Uygulama Merkezi. İstanbul.
32. Ozaslan M, Didem Karagöz I, Kalender ME, Kilic IH, Sari I, Karagöz A (2007). In vivo antitumoral effect of Plantago major L. extract on Balb/C mouse with Ehrlich ascites tumor. Am. J. Chin. Med. 35(5): 841-851.
33. Ozaslan M, Karagöz ID, Kilic IH, Cengiz B, Kalender ME, Guldur ME, Karagöz A, Zumrutdal ME (2009a). Effect of Plantago major sap on Ehrlich ascites tumours in mice. Afr. J. Biotechnol. 8(6): 955-959.
34. Ozaslan M, Zümrütdal ME, Daǧli{dotless}oǧlu K, Kilic IB, Karagöz ID, Kalender ME, Tuzcu M, Colak O and Cengiz B (2009b). Antitumoral Effect of L. inermis in Mice with EAC. Int. J. Pharmacol. 5(4): 263-267.
35. Schmidt H, Siems W, Müler M, Dumdey R, Rapoport SM (1991). ATPProducing and Consuming Processes of Ehrlich Mouse Ascites Tumor Cells in Proliferating and Resting Phases. Exp. Cell Res. 194: 122-127.
36. Schwendel A, Siems WG, Grune T, Holzhütter GH (1994). Transitions of Hepatic Purine Metabolism of Ehrlich Ascites Tumor Bearing Mice in Different Phases of Tumor Growth. Biochem. Mol. Biol. Int. 34(3): 457-463.
37. Segura JA, Ruiz-Bellido MA, Arenas M, Lobo C, Marquez J, Alonso FJ (2001). Ehrlich Ascites Tumor Cells Expressing Anti-Sense Glutaminase RNA Lose Their Capacity to Evade the Mouse İmmune System. Int. J. Cancer, 91: 379-384.
38. Senger DR, Gali SJ, Dvorak MA, Perruzzi CA, Harvey VS, Dvorak HF (1983). Tumor Cells Secrete a Vascular Permeability Factor That Promotes Accumulation of Ascites Fluid. Science, 219: 983-985.
39. Siems W (1989). Changes in the Nucleotide Metabolism of Ehrlich Ascites Tumor Cells during their growth In vivo. Cell. Mol. Biol. 35(3): 255-262.
40. Siems WG, Grune T, Schmidt H, Tikhonov YV, Pimenov MA (1993). Purine Nucleotide Levels in Host Tissues of Ehrlich Ascites Tumor Bearing Mice in different growth phases of the Tumor. Cancer Res. 53: 5143-5147.
41. Skog S, He Q, Tribukait B (1990). Lack of Correlation Between Thymidine Kinase Activity and Changes of DNA Synthesis With Tumour Age: An In Vivo Study in Ehrlich Ascites Tumour. Cell Tissue Kinetics, 23: 603-617.
42. Soini Y, Paakkö P, Letho UP (1998). Histopatological Evaluation of Apoptosis in Cancer. Am. J. Pathol. 153: 1041-1053.
43. Song Z, Varani J, Goldstein IJ (1993). Differences in Cell Surface Carbohydrates and in Laminin and Fibronectin Synthesis Between Adherent and Non-adherent Ehrlich Ascites Tumor Cells. Int. J. Cancer, 55: 1029-1035.
44. Suffiness M, Pezzuto JM (1991). Methods in Plant Biochemistry. Academic Press. New York. 6: p. 71.
45. o Ascites Tumor Cells during Tumor Growth. Cancer Biochem. Biophys. 5: 259-264.
46. Tannock IF (1969). A Comparison of Cell Proliferation parameters in Solid and Ascites Ehrlich Tumors. Cancer Res. 29: 1527-1534.
47. Taşki{dotless}n Eİ (2002). Ehrlich Ascites Tümörü ile Balb-C Farelerde Oluşturulmuş Solid Tümör Modelinde Curcuminin Apoptoz Üzerine Etkileri. İstanbul Üniversitesi Saǧli{dotless}k Bilimleri Enstitüsü Ti{dotless}bbi Biyoloji Anabilim Dali{dotless}. İstanbul.
48. Vinuela JE, Rodriguez R, Gil J, Coll J, Concha E, Subiza JL (1991). Antigen Sheddi{dotless}ng Vs. Development of Natural Suppressor Cells As Mechani{dotless}sm of Tumor Escape in Mice Bearing Ehrlich Tumor. Int. J. Cancer, 47: 86-91.
49. Yeh HW, Burns ER, Yeh YC (1985). Initiation of DNA Synthesis in the Liver and Other Tissues of Adult Mice by a Factor (EACF) Isolated From Acellular Fluid of Ehrlich Ascites Carcinoma. Biosci. Rep. 5: 205-214.
50. Zeybek ŞÜ (1996). En Uygun Ehrlich Ascites Tümör Modellerinin Farkli{dotless} Soy ve Cinsiyetteki Farelerde Gösterilmesi. İstanbul Üniversitesi Saǧli{dotless}k Bilimleri Enstitüsü Deney Hayvanlari{dotless} Biyolojisi ve Biyomedikal Uygulama Teknikleri Anabilim Dali{dotless}. Yüksek Lisans Tezi. İstanbul.